Propofol for tracheal intubation in children anesthetized with sevoflurane: a dose-response study

Area of Science:

• Anesthesiology
• Pediatric Anesthesia
• Pharmacology

Background:

• Tracheal intubation is a critical procedure in pediatric anesthesia.
• Intravenous propofol is commonly used to facilitate intubation during sevoflurane induction.
• Optimal propofol dosage for intubating conditions and respiratory effects in children requires further study.

Purpose of the Study:

• To evaluate the dose-response relationship of intravenous propofol for tracheal intubation.
• To assess the incidence and duration of apnea following propofol administration in pediatric patients.
• To compare intubating conditions and respiratory side effects across different propofol doses.

Main Methods:

• A randomized, dose-response study involving 60 healthy children.
• Children received sevoflurane/nitrous oxide anesthesia with varying doses of intravenous propofol (0, 0.5, 1, 2, or 3 mg/kg).
• Intubating conditions were assessed using a standardized scale; apnea, heart rate, and blood pressure were recorded.

Main Results:

• The 3 mg/kg propofol dose resulted in significantly better laryngoscopy and intubation conditions compared to 0 and 0.5 mg/kg doses.
• Apnea incidence was highest (8/10) with 3 mg/kg propofol, significantly greater than with 0 mg/kg (3/14) and 0.5 mg/kg (3/12).
• Apnea duration and the risk of apnea increased dose-dependently with propofol, while heart rate and blood pressure decreased over time.

Conclusions:

• Intravenous propofol at 3 mg/kg significantly improves tracheal intubating conditions in pediatric patients under sevoflurane/nitrous oxide anesthesia.
• This higher propofol dose is associated with a notable increase in the incidence and duration of apnea.
• Clinicians should carefully weigh the benefits of improved intubating conditions against the increased risk of prolonged apnea when using 3 mg/kg propofol.